DTIL – Precision BioSciences, Inc.
Precision BioSciences, Inc.DTIL
$4.62Name : Precision BioSciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $51,450,168.00
EPSttm : -2.87
Precision BioSciences, Inc.
$4.62
3.35%$0.16Float Short %
13.37
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.03
EPS Last/This Y
-9.79
EPS This/Next Y
1.2
Price
4.62
Target Price
34.33
Analyst Recom
1
Performance Q
-19.23
Relative Volume
0.23
Beta
1.52
Ticker: DTIL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-07 | DTIL | 4.33 | N/A | N/A | 0 |
| 2025-07-08 | DTIL | 4.52 | N/A | N/A | 0 |
| 2025-07-09 | DTIL | 4.75 | N/A | N/A | 0 |
| 2025-07-10 | DTIL | 4.83 | N/A | N/A | 0 |
| 2025-07-11 | DTIL | 4.45 | N/A | N/A | 0 |
| 2025-07-14 | DTIL | 4.64 | N/A | N/A | 0 |
| 2025-07-15 | DTIL | 4.46 | N/A | N/A | 0 |
| 2025-07-16 | DTIL | 4.53 | N/A | N/A | 0 |
| 2025-07-17 | DTIL | 4.65 | N/A | N/A | 0 |
| 2025-07-18 | DTIL | 4.67 | N/A | N/A | 0 |
| 2025-07-21 | DTIL | 4.65 | N/A | N/A | 0 |
| 2025-07-22 | DTIL | 4.89 | N/A | N/A | 0 |
| 2025-07-23 | DTIL | 4.95 | N/A | N/A | 0 |
| 2025-07-24 | DTIL | 5.06 | N/A | N/A | 0 |
| 2025-07-25 | DTIL | 5.16 | N/A | N/A | 0 |
| 2025-07-28 | DTIL | 5.12 | N/A | N/A | 0 |
| 2025-07-29 | DTIL | 4.9 | N/A | N/A | 0 |
| 2025-07-30 | DTIL | 4.79 | N/A | N/A | 0 |
| 2025-07-31 | DTIL | 4.72 | N/A | N/A | 0 |
| 2025-08-01 | DTIL | 4.6 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-07 | DTIL | 4.32 | -147.2 | - | -8.74 |
| 2025-07-08 | DTIL | 4.52 | -147.2 | - | -8.74 |
| 2025-07-09 | DTIL | 4.73 | -147.2 | - | -8.74 |
| 2025-07-10 | DTIL | 4.83 | -147.2 | - | -8.74 |
| 2025-07-11 | DTIL | 4.45 | -147.2 | - | -8.74 |
| 2025-07-14 | DTIL | 4.64 | -147.2 | - | -8.74 |
| 2025-07-15 | DTIL | 4.45 | -147.2 | - | -8.74 |
| 2025-07-16 | DTIL | 4.52 | -147.2 | - | -8.74 |
| 2025-07-17 | DTIL | 4.64 | -147.2 | - | -8.74 |
| 2025-07-18 | DTIL | 4.66 | -147.2 | - | -8.74 |
| 2025-07-21 | DTIL | 4.64 | -147.2 | - | -8.74 |
| 2025-07-22 | DTIL | 4.87 | -147.2 | - | -8.74 |
| 2025-07-23 | DTIL | 4.94 | -147.2 | - | -8.74 |
| 2025-07-24 | DTIL | 5.00 | -147.2 | - | -8.74 |
| 2025-07-25 | DTIL | 5.15 | -147.2 | - | -8.74 |
| 2025-07-28 | DTIL | 5.09 | -147.2 | - | -8.74 |
| 2025-07-29 | DTIL | 4.89 | -147.2 | - | -8.74 |
| 2025-07-30 | DTIL | 4.80 | -147.2 | - | -8.74 |
| 2025-07-31 | DTIL | 4.75 | -147.2 | - | -8.74 |
| 2025-08-01 | DTIL | 4.62 | -147.2 | - | -8.74 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-07 | DTIL | -1.35 | 12.42 | 6.75 |
| 2025-07-08 | DTIL | -1.82 | 12.42 | 6.75 |
| 2025-07-09 | DTIL | -1.82 | 12.42 | 6.75 |
| 2025-07-10 | DTIL | -1.82 | 12.42 | 6.75 |
| 2025-07-11 | DTIL | -1.82 | 12.42 | 16.07 |
| 2025-07-14 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-15 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-16 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-17 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-18 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-21 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-22 | DTIL | -1.83 | 12.42 | 16.03 |
| 2025-07-23 | DTIL | 0.01 | 12.42 | 16.03 |
| 2025-07-24 | DTIL | 0.01 | 12.42 | 16.03 |
| 2025-07-25 | DTIL | 0.01 | 12.42 | 13.37 |
| 2025-07-28 | DTIL | 0.01 | 12.42 | 13.37 |
| 2025-07-29 | DTIL | 0.01 | 12.42 | 13.37 |
| 2025-07-30 | DTIL | 0.01 | 12.42 | 13.37 |
| 2025-07-31 | DTIL | 0.01 | 12.42 | 13.37 |
| 2025-08-01 | DTIL | 0.01 | 12.42 | 13.37 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.21
Avg. EPS Est. Current Quarter
-2.21
Avg. EPS Est. Next Quarter
-2.24
Insider Transactions
0.01
Institutional Transactions
12.42
Beta
1.52
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
25
Growth Score
41
Sentiment Score
33
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.2
Target Price
34.33
P/E
Forward P/E
PEG
P/S
1
P/B
0.99
P/Free Cash Flow
EPS
-2.01
Average EPS Est. Cur. Y
-8.74
EPS Next Y. (Est.)
-7.55
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-42.99
Relative Volume
0.23
Return on Equity vs Sector %
-68.3
Return on Equity vs Industry %
-49.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 107
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading